Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| tau Proteins | 6 | 2021 | 61 | 1.680 |
Why?
|
| Receptor, Cannabinoid, CB1 | 7 | 2018 | 68 | 1.280 |
Why?
|
| Brain | 12 | 2022 | 2176 | 0.950 |
Why?
|
| Lymph Nodes | 2 | 2022 | 258 | 0.920 |
Why?
|
| Aging | 9 | 2022 | 911 | 0.840 |
Why?
|
| Meninges | 1 | 2022 | 7 | 0.810 |
Why?
|
| Cranial Sinuses | 1 | 2022 | 11 | 0.810 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2020 | 105 | 0.760 |
Why?
|
| GABAergic Neurons | 2 | 2018 | 17 | 0.680 |
Why?
|
| Reflex | 1 | 2019 | 21 | 0.680 |
Why?
|
| Urination | 1 | 2019 | 19 | 0.680 |
Why?
|
| Epilepsy | 1 | 2022 | 336 | 0.600 |
Why?
|
| Brain Injuries | 2 | 2017 | 268 | 0.570 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2016 | 12 | 0.530 |
Why?
|
| Long-Term Potentiation | 1 | 2016 | 53 | 0.520 |
Why?
|
| Interneurons | 1 | 2016 | 70 | 0.500 |
Why?
|
| Disease Models, Animal | 7 | 2018 | 2550 | 0.470 |
Why?
|
| Hippocampus | 6 | 2018 | 471 | 0.430 |
Why?
|
| Alzheimer Disease | 5 | 2021 | 565 | 0.360 |
Why?
|
| Animals | 23 | 2021 | 20881 | 0.340 |
Why?
|
| Chronic Traumatic Encephalopathy | 2 | 2020 | 2 | 0.330 |
Why?
|
| Cognition | 5 | 2017 | 513 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 2791 | 0.320 |
Why?
|
| Endocannabinoids | 4 | 2017 | 32 | 0.310 |
Why?
|
| Behavior, Animal | 3 | 2017 | 470 | 0.290 |
Why?
|
| Mice, Knockout | 10 | 2018 | 1692 | 0.280 |
Why?
|
| Tauopathies | 2 | 2017 | 6 | 0.270 |
Why?
|
| Cognitive Dysfunction | 2 | 2021 | 176 | 0.270 |
Why?
|
| Mice | 14 | 2021 | 8474 | 0.260 |
Why?
|
| Receptor, Cannabinoid, CB2 | 2 | 2016 | 27 | 0.260 |
Why?
|
| Maze Learning | 3 | 2016 | 138 | 0.250 |
Why?
|
| Dronabinol | 2 | 2017 | 84 | 0.250 |
Why?
|
| Lipofuscin | 2 | 2015 | 43 | 0.230 |
Why?
|
| Microglia | 2 | 2014 | 143 | 0.220 |
Why?
|
| Male | 14 | 2022 | 37321 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 2223 | 0.220 |
Why?
|
| Bacteroidaceae Infections | 1 | 2022 | 15 | 0.200 |
Why?
|
| Porphyromonas gingivalis | 1 | 2022 | 33 | 0.200 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 2 | 2021 | 7 | 0.190 |
Why?
|
| Dementia, Vascular | 1 | 2021 | 22 | 0.190 |
Why?
|
| Memory | 2 | 2014 | 214 | 0.190 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 189 | 0.180 |
Why?
|
| Cognition Disorders | 2 | 2015 | 342 | 0.180 |
Why?
|
| Axons | 2 | 2017 | 139 | 0.170 |
Why?
|
| Adolescent | 3 | 2022 | 8912 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2022 | 384 | 0.160 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2019 | 41 | 0.160 |
Why?
|
| Lipoprotein Lipase | 2 | 2015 | 5 | 0.160 |
Why?
|
| Urinary Bladder | 1 | 2019 | 108 | 0.160 |
Why?
|
| Motor Activity | 3 | 2017 | 621 | 0.160 |
Why?
|
| Sex Factors | 1 | 2022 | 1266 | 0.150 |
Why?
|
| Case-Control Studies | 1 | 2022 | 1553 | 0.150 |
Why?
|
| Temperature | 1 | 2019 | 341 | 0.150 |
Why?
|
| Female | 11 | 2022 | 38074 | 0.150 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 46 | 0.150 |
Why?
|
| Cognitive Aging | 1 | 2017 | 3 | 0.150 |
Why?
|
| Chemokine CCL17 | 1 | 2016 | 2 | 0.140 |
Why?
|
| Malaria, Cerebral | 1 | 2016 | 3 | 0.140 |
Why?
|
| Plasmodium berghei | 1 | 2016 | 7 | 0.140 |
Why?
|
| Dendritic Spines | 1 | 2017 | 76 | 0.140 |
Why?
|
| Phenotype | 1 | 2019 | 947 | 0.130 |
Why?
|
| Aged | 3 | 2022 | 14862 | 0.130 |
Why?
|
| Blood-Brain Barrier | 1 | 2016 | 99 | 0.130 |
Why?
|
| Aged, 80 and over | 2 | 2022 | 4848 | 0.130 |
Why?
|
| Glycerides | 1 | 2015 | 18 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2018 | 626 | 0.130 |
Why?
|
| Telencephalon | 1 | 2015 | 6 | 0.130 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2015 | 17 | 0.130 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2015 | 17 | 0.130 |
Why?
|
| Neurogenesis | 2 | 2015 | 32 | 0.130 |
Why?
|
| Arachidonic Acids | 1 | 2015 | 97 | 0.130 |
Why?
|
| Mental Disorders | 1 | 2020 | 659 | 0.130 |
Why?
|
| Amidohydrolases | 1 | 2014 | 60 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2017 | 1200 | 0.120 |
Why?
|
| Spatial Behavior | 1 | 2014 | 18 | 0.120 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2014 | 20 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2015 | 718 | 0.120 |
Why?
|
| Middle Aged | 3 | 2022 | 21147 | 0.110 |
Why?
|
| Fear | 1 | 2015 | 239 | 0.110 |
Why?
|
| Cathepsin D | 1 | 2013 | 13 | 0.110 |
Why?
|
| Adult | 3 | 2022 | 21403 | 0.110 |
Why?
|
| Learning | 1 | 2015 | 186 | 0.110 |
Why?
|
| Serine | 1 | 2013 | 99 | 0.110 |
Why?
|
| Neurocan | 1 | 2012 | 6 | 0.110 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 1851 | 0.110 |
Why?
|
| Humans | 11 | 2022 | 68618 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 511 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 103 | 0.100 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.100 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 20 | 0.100 |
Why?
|
| Mitochondrial Diseases | 1 | 2011 | 24 | 0.100 |
Why?
|
| Cell Count | 1 | 2011 | 248 | 0.090 |
Why?
|
| Young Adult | 2 | 2022 | 5717 | 0.090 |
Why?
|
| Skin Aging | 1 | 2010 | 8 | 0.090 |
Why?
|
| Neuroglia | 1 | 2011 | 136 | 0.090 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 1033 | 0.090 |
Why?
|
| Anxiety Disorders | 1 | 2013 | 426 | 0.090 |
Why?
|
| Bipolar Disorder | 1 | 2012 | 307 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2011 | 330 | 0.090 |
Why?
|
| Gene Deletion | 1 | 2010 | 235 | 0.080 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7277 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2011 | 208 | 0.080 |
Why?
|
| Seizures | 1 | 2011 | 279 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2015 | 824 | 0.080 |
Why?
|
| Gene Expression | 1 | 2011 | 770 | 0.080 |
Why?
|
| Oxygen | 2 | 2013 | 386 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2011 | 296 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2011 | 597 | 0.080 |
Why?
|
| Skin | 1 | 2010 | 451 | 0.070 |
Why?
|
| Spatial Learning | 2 | 2017 | 12 | 0.070 |
Why?
|
| Depression | 1 | 2013 | 943 | 0.070 |
Why?
|
| Neurons | 1 | 2011 | 881 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2005 | 21 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2005 | 38 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2005 | 25 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 38 | 0.060 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 94 | 0.060 |
Why?
|
| Astrocytes | 2 | 2018 | 270 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2014 | 92 | 0.060 |
Why?
|
| Zebrafish | 2 | 2015 | 187 | 0.060 |
Why?
|
| Carotid Artery, Common | 1 | 2022 | 25 | 0.050 |
Why?
|
| Base Composition | 1 | 2022 | 22 | 0.050 |
Why?
|
| Receptors, Endothelin | 1 | 2022 | 30 | 0.050 |
Why?
|
| Receptor, Endothelin B | 1 | 2022 | 34 | 0.050 |
Why?
|
| Receptor, Endothelin A | 1 | 2022 | 35 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2022 | 85 | 0.050 |
Why?
|
| Endothelins | 1 | 2022 | 57 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2022 | 208 | 0.050 |
Why?
|
| Genotype | 2 | 2014 | 786 | 0.050 |
Why?
|
| Phylogeny | 1 | 2022 | 197 | 0.050 |
Why?
|
| Psychopathology | 1 | 2020 | 29 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 981 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2022 | 122 | 0.050 |
Why?
|
| Exploratory Behavior | 2 | 2015 | 79 | 0.040 |
Why?
|
| Cytokines | 2 | 2014 | 866 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2021 | 215 | 0.040 |
Why?
|
| Inflammation | 2 | 2014 | 1030 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 5 | 0.040 |
Why?
|
| Memory, Long-Term | 1 | 2017 | 4 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2017 | 9 | 0.040 |
Why?
|
| Acetylation | 1 | 2017 | 94 | 0.040 |
Why?
|
| Behavior Rating Scale | 1 | 2017 | 7 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2016 | 8 | 0.030 |
Why?
|
| Arginase | 1 | 2016 | 15 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2016 | 39 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2015 | 2 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2016 | 144 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 164 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2015 | 26 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2016 | 179 | 0.030 |
Why?
|
| Association Learning | 1 | 2015 | 36 | 0.030 |
Why?
|
| Discrimination Learning | 1 | 2015 | 45 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 204 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 328 | 0.030 |
Why?
|
| Maternal Behavior | 1 | 2015 | 29 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 248 | 0.030 |
Why?
|
| Epitopes | 1 | 2015 | 146 | 0.030 |
Why?
|
| Cell Size | 1 | 2014 | 76 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 101 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1174 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2015 | 202 | 0.030 |
Why?
|
| Chemokines | 1 | 2014 | 119 | 0.030 |
Why?
|
| Social Behavior | 1 | 2015 | 164 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2015 | 215 | 0.030 |
Why?
|
| Racemases and Epimerases | 1 | 2013 | 2 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 229 | 0.030 |
Why?
|
| Extinction, Psychological | 1 | 2015 | 240 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2013 | 282 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 191 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 244 | 0.030 |
Why?
|
| Lysosomes | 1 | 2013 | 136 | 0.030 |
Why?
|
| Macrophages | 1 | 2016 | 647 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2012 | 55 | 0.030 |
Why?
|
| Lithium | 1 | 2012 | 76 | 0.030 |
Why?
|
| Alleles | 1 | 2012 | 386 | 0.020 |
Why?
|
| Autophagy | 1 | 2013 | 208 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 615 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 1038 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2012 | 206 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 216 | 0.020 |
Why?
|
| Hearing | 1 | 2010 | 133 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2673 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2358 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 2689 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 786 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 499 | 0.020 |
Why?
|
| Depressive Disorder, Major | 1 | 2012 | 439 | 0.020 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2005 | 3 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2005 | 5 | 0.020 |
Why?
|
| Locomotion | 1 | 2005 | 135 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 261 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 7029 | 0.010 |
Why?
|